Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus

Hypertension

Volumn 35, Issue 6, 2000, Pages 1248-1252

  Gironacci, Mariela M ^b   Vatta, Marcelo ^b   Rodriguez Fermepín, Martín ^b   Fernández, Belisario E ^b   Peña, Clara ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

Angiotensin; Angiotensin antagonist; Bradykinin; Nitric oxide; Norepinephrine; Prostaglandins

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN[1-7]; LOSARTAN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HYPERTENSION; HYPOTHALAMUS; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY;

EID: 0034125296     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.6.1248     Document Type: Article

References (40)

1. Ferrario CM, Brosnihan KB, Diz DI, Jaiswal N, Khosla MC, Milsted A, Tallan EA. Angiotensin-(1-7): a new hormone of the angiotensin system. Hypertension. 1991;18(suppl III):III-126-III-133.
2. Ferrario CM, Barnes KL, Block CH, Brosnihan KB, Diz DI, Khosla MC, Santos RAS. Pathways of angiotensin formation and function in the brain. Hypertension. 1990;15(suppl I):I-13-I-19.
3. Bottari SP, de Gasparo M, Steckelings M, Leven NR. Angiotensin II receptors subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol. 1993;14:123-171.
4. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993; 45:205-251.
5. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC. Biological activities of angiotensin II-(1-6)-hexapeptide and angiotensin II-(1-7)-heptapeptide in man. Life Sci. 1986;38:1515-1519.
6. Fitzsimons JT. The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon. J Physiol. 1971;214:295-303.
7. Santos RAS, Campagnole-Santos MJ. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res. 1994;27:1033-1047.
8. 3H]-norepinephrine from rat atria. Hypertension. 1994;24:457-460.
9. Jaiswal N, Tallant EA, Diz DI, Khosla MC, Ferrario CM. Subtype 2 angiotensin receptors mediate prostaglandin synthesis in human astrocytes. Hypertension. 1991;17:1115-1120.
10. Jaiswal N, Diz DI, Chappell MC, Khosla MC, Ferrario CM. Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension. 1992;19(suppl II):II-49-II-55.
11. Trachte GJ, Meixner K, Ferrario CM, Khosla MC. Prostaglandin production in response to angiotensin-(1-7) in rabbit isolated vasa deferentia. Prostaglandins. 1990;39:385-394.
12. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A. 1988;85:4095-4098.
13. Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28: 104-108.
14. DelliPizzi AM, Hilchey SD, Bell-Quilley CP. Natriuretic action of angiotensin-(1-7). Br J Pharmacol. 1994;111:1-3.
15. Handa RK, Ferrario CM, Strandhoy JW. Renal actions of angiotensin-(1-7): in vivo and in vitro studies. Am J Physiol. 1996;270:F141-F147.
16. Osei SY, Ahima RS, Minkes RK, Weaver JP, Khosla MC, Kadowitz PJ. Differential responses to angiotensin-(1-7) in the feline mesenteric and hindquarters vascular beds. Eur J Pharmacol. 1993;234:35-42.
17. Pörsti I, Bara AT, Busse R, Hecker M. Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor. Br J Pharmacol. 1994;111:652-654.
18. Britto RR, Santos RAS, Fagundes-Moura CR, Khosla MC, Campagnole-Santos MJ. Role of angiotensin-(1-7) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension. 1997;30(part 2):549-556.
19. López Ordieres MG, Gironacci MM, Rodríguez de Lores Arnaiz G, Peña C. Effect of angiotensin-(1-7) on ATPase activities in several tissues. Regul Peptides. 1998;77:135-139.
20. +-ATPase inhibitor (Endobain E) enhances norepinephrine release in rat hypothalamus. Neuroscience. 1999;90:573-579.
21. Brosnihan KB, Li P, Ferrario CM. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension. 1996;27(part 2):523-528.
22. Gironacci MM, Lorenzo PS, Adler-Graschinsky E. Possible participation of nitric oxide in the increase of norepinephrine release caused by angiotensin peptides in rat atria. Hypertension. 1997;29:1344-1350.
23. Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995;25:796-802.
24. Inagami T. Molecular biology and signaling of angiotensin receptors: an overview. J Am Soc Nephrol. 1999;10:S2-S7.
25. 2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506-6510.
26. Diz DI, Pirro NT. Differential actions of angiotensin II and angiotensin-(1-7) on transmitter release. Hypertension. 1992;19(suppl II):II-41-11-48.
27. Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counterregulatory actions of angiotensin-(1-7). Hypertension. 1997;30(part 2):535-541.
28. Schunker H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expression by angiotensin II. Am J Physiol. 1992;263: E863-E869.
29. Timmermans PBMWM, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD. Angiotensin II receptors and functional correlates. Am J Hypertens. 1992;5:221S-235S.
30. Vatta MS, Bianciotti LG, Papouchado ML, Locatelli AS, Polidoro-Arena J, Fernandez BE. Modulation of noradrenergic neurotransmission by angiotensin II and angiotensin III. Pharmacodynamics Therapeutics (Life Sci Adv). 1990;9:177-185.
31. Vatta MS, Papouchado ML, Bianciotti LG, Fernandez BE. Atrial natriuretic factor inhibits noradrenaline release in the presence of angiotensin II and III in the rat hypothalamus. Comp Biochem Physiol. 1993;106C:545-548.
32. Diz DI, Bosch SM, Westwood B. Identification of angiotensin receptor subtypes mediating substance P release in brain slices of hypothalamus and medulla. Hypertension. 1998;32:594. Abstract.
33. Ambühl P, Felix D, Khosla MC. [7-D-Ala]-angiotensin-(1-7): selective antagonism of angiotensin-(1-7) in the rat paraventricular nucleus. Brain Res Bull. 1994;35:289-291.
34. Muthalif MM, Benter IF, Uddin MR, Harper JL, Malik KU. Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J Pharmacol Exp Ther. 1998;284:388-398.
35. Kumagai K, Reid IA. Losartan inhibits sympathetic and cardiovascular responses to carotid occlusion. Hypertension. 1994;23(part 2):827-831.
36. Suzuki Y, Matsumura Y, Egi Y, Morimoto S. Effects of losartan, a nonpeptide angiotensin II receptor antagonist on norepinephrine overflow and antidiuresis induced by stimulation of renal nerves in anesthetized dogs. J Pharmacol Exp Ther. 1992;263:956-963.
37. Ardaillou R, Chansel D. Synthesis and effects of active fragments of angiotensin II. Kidney Int. 1998;52:1458-1468.
38. Seyedi N, Xu X, Nasjletti A, Hintze TH. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation. Hypertension. 1995;26:164-170.
39. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29(part 2):394-400.
40. Deddish PA, Marcic B, Jackman HL, Wang H, Skidgel RA, Erdös EG. N-Domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme. Hypertension. 1998;31:912-917.